AUROPHARMA

Aurobindo Pharma, a large-cap player in the pharmaceuticals and drugs industry, experienced a significant decline in its stock price on February 19, 2025, with a loss of 5.51%. The stock underperformed its sector by 5.72%, marking a challenging day for investors. Opening with a gap down, Aurobindo Pharma's stock fell by 4.52% at the start of trading and reached an intraday low of Rs 1053.45, reflecting a drop of 9.38%. The stock has shown high volatility, with an intraday fluctuation of 18.34%. Over the past two days, Aurobindo Pharma has seen a consecutive decline, resulting in a total return loss of 7.67%. In terms of moving averages, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages. In comparison to the broader market, Aurobindo Pharma's one-day performance of -5.26% contrasts with the Sensex's modest decline of 0.41%. Over the past month, the stock has decreased by 6.49%, while the Sensex has fallen by 1.26%.